On this page · 5 sections→
Where the EU money came from
Funding by EU programme. Amounts are Cellzome AG's own share of each project, not the project's full budget.
- FP7 (2007 to 2013)€1.5M · 3 projects
Projects
3 EU-funded projects, newest first. Each links to the official record.
- OVER-MYRPartner
Overcoming clinical relapse in multiple myeloma by understanding and targeting the molecular causes of drug resistance
FP7 (2007 to 2013) · 2012–2015 · Project on CORDIS ↗
- BLUEPRINTPartner
A BLUEPRINT of Haematopoietic Epigenomes
FP7 (2007 to 2013) · 2011–2016 · Project on CORDIS ↗
€1.2Mtheir share - ORCHIDPartner
Open Collaborative Model for Tuberculosis Lead Optimisation
FP7 (2007 to 2013) · 2011–2015 · Project on CORDIS ↗
€300ktheir share
Works most with
Organisations that shared the most EU projects with this one. A good starting list for consortium partners.
- Institut National de la Sante et de la Recherche MedicaleFrance · 3 shared projects
- Cellzome GmbHGermany · 2 shared projects
- Centre National de la Recherche Scientifique CNRSFrance · 1 shared project
- Max-Planck-Gesellschaft zur Forderung der Wissenschaften eVGermany · 1 shared project
- The Chancellor Masters and Scholars of the University of CambridgeUnited Kingdom · 1 shared project
- Kobenhavns UniversitetDenmark · 1 shared project
- Ecole Polytechnique Federale de LausanneSwitzerland · 1 shared project
- University College LondonUnited Kingdom · 1 shared project
- The University of EdinburghUnited Kingdom · 1 shared project
- Weizmann Institute of ScienceIsrael · 1 shared project
- Stichting Radboud UniversiteitNetherlands · 1 shared project
- Lunds UniversitetSweden · 1 shared project
- European Molecular Biology LaboratoryGermany · 1 shared project
- Erasmus Universitair Medisch Centrum RotterdamNetherlands · 1 shared project
- The University of BirminghamUnited Kingdom · 1 shared project
- Vrije Universiteit BrusselBelgium · 1 shared project
Fields it works in
Research fields recorded on its Horizon projects.
- autoimmune diseases
- drug discovery
- drug resistance
- epigenetics
- genomes
- leukemia
- tuberculosis
Is this your organisation?
Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.
Claim this profile →Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗
